Bio Focus Co., Ltd.

[Gyeonggi-Do South Korea ]

  • 1st
Business Type:
Manufacturer
Year Established:
1999
Total Revenue:
US$1 Million - US$2.5 Million
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe

Company Description

Bio Focus is R&D based manufacturer for in vitro diagnostic products from South Korea.

We are focusing efforts on Point-of-Care Testing as core strategic business for the new healthcare environment in 21th century.

We are also developing proprietary and unique technologies for world-class rapid immunochromatographic assay and biosensor systems.

Bio Focus hsa established it's unique position in IVDT industry as total solution provider for a wide range of rapid tests, semi-finished products and raw materials. In addition, we are wxpanding into more advanced digital POCT systems using our strong background in molecular biology and microfluidics technology.

Our R&D center and factory located in Uiwang city, nearby Seoul, are up-to-dated manufacturing facilities equipped to produce monoclonal antibody, colloidal gold and various rapid tests. Our main factory was built up since 2001 which approved for manufacturing IVD products from KFDA and operated under quality system of ISO 13485.

Most of our products are certified with CE or US FDA.

We are currently providing an extensive range of immunochromatography based one-step rapid tests for infectious disease & STD for HBsAg, HBsAb, HCV, HIV 1/2, Syphilis, Norovirus, Rotavirus, Adenovirus, Tumor markers for AFP, CEA, PSA, FOB and Cardiac markers for Troponin I, Myoglobin, CK-MB and other unique rapid tests such as Influenza A&B and HSV-2, Malaria, Dengue, TB and H. Pylori. Beyond that, we also produce highly sensitive urine pregnancy test and ovulation test for professional use and self-testing under our own brand name, Bio Tracer and on an OEM basis.

Our accumulated technologies and experience guarantee the highest quality products at competitive prices.

In addition, we are developing new POCT system for quantitative rapid assay using highly specific monoclonal antibody and nano complex based workstation.

We appreciate again for your interest in our products and look forward more cooperation in near future.